Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
European Annals of Otorhinolaryngology, Head and Neck Diseases|October 22, 2023
Surgical and instrumental options for chronic rhinitis: A systematic review and PRISMA meta-analysisM Fieux, F Carsuzaa, M Nourredine, et al.
Rhinology|January 5, 2026
Regional disparities in cost-effectiveness of biologics for CRSwNP should not modify the strategyM Fieux, F Carsuzaa, M Chang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 13, 2009
A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenesC Martinaud, A Doloy, B Graffin, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|April 10, 2009
Endovascular management of chronic disabling ilio-caval obstructive lesions: long-term resultsO Hartung, A D Loundou, P Barthelemy, et al.
Thrombosis Research|August 1, 1989
Intraoperative evolution of coagulation parameters and t-PA/PAI balance in orthotopic liver transplantationD Arnoux, B Boutière, M Houvenaeghel, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Blue nevus of the scalp associated with a meningeal melanocytoma]P Alla, F Carsuzaa, J Fesselet, et al.
Joint Bone Spine|April 19, 2000
Antiphospholipid syndrome and factor V Leiden. Three cases with recurrent venous thrombosisS Guis-Sabatier, J Roudier, D Arnoux, et al.
Transplantation|December 27, 1994
Plasma thrombomodulin in orthotopic liver transplantationB Boutiere, D Arnoux, M C Boffa, et al.
Thrombosis and Haemostasis|October 28, 1987
Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assayE Anglés-Cano, B Boutière, D Arnoux, et al.
Journal of the National Cancer Institute|February 15, 1989
Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231N Pourreau-Schneider, P Delori, B Boutière, et al.
Pageof 7